I(chten)Fe(ls) trial on the intensity of the nocebo effect concerning potential adverse effects after covid-19 vaccination based on the elaborateness of the medical briefing
Not Applicable
- Conditions
- The trial hypothesis says that a concise medical briefing before SARS-CoV-2 vaccination can reduce the occurence and intensity of vaccination associated adverse effects.
- Registration Number
- DRKS00026091
- Lead Sponsor
- Impfzentrum Lichtenfels
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 4334
Inclusion Criteria
Only patients that were willing and able to give consent are included in this study.
Exclusion Criteria
Patients that were not willing or unable to give consent were not included in this study.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method General occurrence of adverse effects, that can be attributed to the vaccination. Specification of the adverse effects that possibly occurred and their intensity. <br>Use of painkillers to reduce the adverse effects and, if yes, specification of the painkiller.<br>Requirement of a doctoral sick note after the vaccination and, if yes, duration of sick leave. <br>These points are queried using an online or offline questionnaire 5 days after the vaccination (multiple choice).
- Secondary Outcome Measures
Name Time Method Rating of the visit at the Lichtenfels Vaccination Center. Satisfaction with the medical briefing.